Hyderabad Telangana, India

Gona Bala Narashimha Reddy

This inventor holds 1 USPTO granted patent. Top assignee: Aurobindo Pharma Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gona Bala Narashimha Reddy. Retrieved from https://idiyas.com/inventor/gona-bala-narashimha-reddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gona Bala Narashimha Reddy: Innovator in Pharmaceutical Crystallization

Introduction

Gona Bala Narashimha Reddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of crystalline forms of important compounds. His work is essential for the development of effective medications.

Latest Patents

Gona Bala Narashimha Reddy holds a patent for the "Process for the preparation of Mirabegron alpha-form crystals." This invention provides a process for the preparation of α-Form crystals of Mirabegron using a solvent selected from water. This innovation is crucial for enhancing the solubility and bioavailability of the drug.

Career Highlights

He is currently associated with Aurobindo Pharma Limited, a leading pharmaceutical company known for its commitment to quality and innovation. His role at Aurobindo Pharma Limited allows him to contribute to the development of new pharmaceutical products that can improve patient outcomes.

Collaborations

Gona Bala Narashimha Reddy has collaborated with talented coworkers such as Sukumar Nandi and Shantan Kumar Reddy. These collaborations have fostered a productive environment for innovation and research within the company.

Conclusion

Gona Bala Narashimha Reddy is a prominent figure in the pharmaceutical industry, with a focus on innovative crystallization processes. His contributions are vital for the advancement of drug formulation and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…